AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
EMERGENCE AND INFECTIOUS COMPLICATIONS OF CIPROFLOXACIN-RESISTANT ESCHERICHIA-COLI IN HEMATOLOGICAL CANCER-PATIENTS
Authors: VANKRAAIJ MGJ DEKKER AW PETERS E FLUIT A VERDONCK LF ROZENBERGARSKA M
Citation: Mgj. Vankraaij et al., EMERGENCE AND INFECTIOUS COMPLICATIONS OF CIPROFLOXACIN-RESISTANT ESCHERICHIA-COLI IN HEMATOLOGICAL CANCER-PATIENTS, European journal of clinical microbiology & infectious diseases, 17(8), 1998, pp. 591-592
MITOXANTRONE VERSUS DAUNORUBICIN IN INDUCTION-CONSOLIDATION CHEMOTHERAPY - THE VALUE OF LOW-DOSE CYTARABINE FOR MAINTENANCE OF REMISSION, AND AN ASSESSMENT OF PROGNOSTIC FACTORS IN ACUTE MYELOID-LEUKEMIA IN THE ELDERLY - FINAL REPORT OF THE LEUKEMIA COOPERATIVE GROUP OF THE ANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER AND THE DUTCH-BELGIAN HEMATOONCOLOGY COOPERATIVE HOVON GROUP RANDOMIZED PHASE-III STUDY AML-9
Authors: LOWENBERG B SUCIU S ARCHIMBAUD E HAAK H STRYCKMANS P DECATALDO R DEKKER AW BERNEMAN ZN THYSS A VANDERLELIE J SONNEVELD P VISANI G FILLET G HAYAT M HAGEMEIJER A SOLBU G ZITTOUN R
Citation: B. Lowenberg et al., MITOXANTRONE VERSUS DAUNORUBICIN IN INDUCTION-CONSOLIDATION CHEMOTHERAPY - THE VALUE OF LOW-DOSE CYTARABINE FOR MAINTENANCE OF REMISSION, AND AN ASSESSMENT OF PROGNOSTIC FACTORS IN ACUTE MYELOID-LEUKEMIA IN THE ELDERLY - FINAL REPORT OF THE LEUKEMIA COOPERATIVE GROUP OF THE ANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER AND THE DUTCH-BELGIAN HEMATOONCOLOGY COOPERATIVE HOVON GROUP RANDOMIZED PHASE-III STUDY AML-9, Journal of clinical oncology, 16(3), 1998, pp. 872-881
LUNG-RESISTANCE-RELATED PROTEIN EXPRESSION IS A NEGATIVE PREDICTIVE FACTOR FOR RESPONSE TO CONVENTIONAL LOW BUT NOT TO INTENSIFIED DOSE ALKYLATING CHEMOTHERAPY IN MULTIPLE-MYELOMA
Authors: RAAIJMAKERS HGP IZQUIERDO MAI LOKHORST HM DELEEUW C BELIEN JAM BLOEM AC DEKKER AW SCHEPER RJ SONNEVELD P
Citation: Hgp. Raaijmakers et al., LUNG-RESISTANCE-RELATED PROTEIN EXPRESSION IS A NEGATIVE PREDICTIVE FACTOR FOR RESPONSE TO CONVENTIONAL LOW BUT NOT TO INTENSIFIED DOSE ALKYLATING CHEMOTHERAPY IN MULTIPLE-MYELOMA, Blood, 91(3), 1998, pp. 1029-1036
A RISK-ADAPTED APPROACH WITH A SHORT-COURSE OF GANCICLOVIR TO PREVENTCYTOMEGALOVIRUS (CMV) PNEUMONIA IN CMV-SEROPOSITIVE RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS
Authors: VERDONCK LF DEKKER AW ROZENBERGARSKA M VANDENHOEK MR
Citation: Lf. Verdonck et al., A RISK-ADAPTED APPROACH WITH A SHORT-COURSE OF GANCICLOVIR TO PREVENTCYTOMEGALOVIRUS (CMV) PNEUMONIA IN CMV-SEROPOSITIVE RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS, Clinical infectious diseases, 24(5), 1997, pp. 901-907
INTENSIVE POSTREMISSION CHEMOTHERAPY WITHOUT MAINTENANCE THERAPY IN ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: DEKKER AW VANTVEER MB SIZOO W HAAK HL VANDERLELIE J OSSENKOPPELE G HUIJGENS PC SCHOUTEN HC SONNEVELD P WILLEMZE R VERDONCK LF VANPUTTEN WLJ LOWENBERG B
Citation: Aw. Dekker et al., INTENSIVE POSTREMISSION CHEMOTHERAPY WITHOUT MAINTENANCE THERAPY IN ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 15(2), 1997, pp. 476-482
LEUKEMIA-CUTIS - A CLINICOPATHOLOGICAL ANALYSIS OF 29 PATIENTS
Authors: VANVLOTEN WA DANKERLUI JOSE TOONSTRA J VANDEPUTTE SCJ DEKKER AW
Citation: Wa. Vanvloten et al., LEUKEMIA-CUTIS - A CLINICOPATHOLOGICAL ANALYSIS OF 29 PATIENTS, Journal of investigative dermatology, 109(3), 1997, pp. 491-491
USE OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DURING AND AFTER REMISSION INDUCTION CHEMOTHERAPY IN PATIENTS AGED 61 YEARS AND OLDER WITH ACUTE MYELOID-LEUKEMIA (AML) - FINAL REPORT OF AML-11, A PHASE-III RANDOMIZED STUDY OF THE LEUKEMIA COOPERATIVE GROUP OFANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC-LCG) AND THE DUTCH BELGIAN HEMATOONCOLOGY COOPERATIVE GROUP (HOVON)
Authors: LOWENBERG B SUCIU S ARCHIMBAUD E OSSENKOPPELE G VERHOEF GEG VELLENGA E WIJERMANS P BERNEMAN Z DEKKER AW STRYCKMANS P SCHOUTEN H JEHN U MUUS P SONNEVELD P DARDENNE M ZITTOUN R
Citation: B. Lowenberg et al., USE OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DURING AND AFTER REMISSION INDUCTION CHEMOTHERAPY IN PATIENTS AGED 61 YEARS AND OLDER WITH ACUTE MYELOID-LEUKEMIA (AML) - FINAL REPORT OF AML-11, A PHASE-III RANDOMIZED STUDY OF THE LEUKEMIA COOPERATIVE GROUP OFANIZATION-FOR-THE-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC-LCG) AND THE DUTCH BELGIAN HEMATOONCOLOGY COOPERATIVE GROUP (HOVON), Blood, 90(8), 1997, pp. 2952-2961
DOSE-FINDING STUDY OF PSC833, A NOVEL MDR REVERSING AGENT, WITH DAUNORUBICIN AND ARA-C IN UNTREATED ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)
Authors: SONNEVELD P LOWENBERG B VOSSEBELD P MALKHANDI J COVELLI A DEKKER AW OSSENKOPPELE G MILLIGAN D VERHOEF G FERRANT A YIN J GRATWOHL A KOVACSOVICS T BURNETT A
Citation: P. Sonneveld et al., DOSE-FINDING STUDY OF PSC833, A NOVEL MDR REVERSING AGENT, WITH DAUNORUBICIN AND ARA-C IN UNTREATED ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML), Blood, 90(10), 1997, pp. 2517-2517
ALLOGENEIC VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: VERDONCK LF DEKKER AW LOKHORST HM PETERSEN EJ NIEUWENHUIS HK
Citation: Lf. Verdonck et al., ALLOGENEIC VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE NON-HODGKINS-LYMPHOMA, Blood, 90(10), 1997, pp. 4201-4205
ALLOGENEIC BONE-MARROW TRANSPLANTATION CAN RESTORE CD4(-LYMPHOCYTE COUNT AND IMMUNE FUNCTION IN IDIOPATHIC CD4(+) T-LYMPHOCYTOPENIA() T)
Authors: PETERSEN EJ ROZENBERGARSKA M DEKKER AW CLEVERS HC VERDONCK LF
Citation: Ej. Petersen et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION CAN RESTORE CD4(-LYMPHOCYTE COUNT AND IMMUNE FUNCTION IN IDIOPATHIC CD4(+) T-LYMPHOCYTOPENIA() T), Bone marrow transplantation, 18(4), 1996, pp. 813-815
GRAFT-VERSUS-MYELOMA EFFECT IN 2 CASES
Authors: VERDONCK LF LOKHORST HM DEKKER AW NIEUWENHUIS HK PETERSEN EJ
Citation: Lf. Verdonck et al., GRAFT-VERSUS-MYELOMA EFFECT IN 2 CASES, Lancet, 347(9004), 1996, pp. 800-801
INTERMEDIATE-DOSE MELPHALAN (IDM) COMBINED WITH G-CSF (FILGRASTIM) ISAN EFFECTIVE AND SAFE INDUCTION THERAPY FOR AUTOLOGOUS STEM-CELL, TRANSPLANTATION IN MULTIPLE-MYELOMA
Authors: LOKHORST HM SONNEVELD P WIJERMANS PW KOOY MV MEUWISSEN OJAT VANOERS RHJ VANDERGRIEND R DEKKER AW
Citation: Hm. Lokhorst et al., INTERMEDIATE-DOSE MELPHALAN (IDM) COMBINED WITH G-CSF (FILGRASTIM) ISAN EFFECTIVE AND SAFE INDUCTION THERAPY FOR AUTOLOGOUS STEM-CELL, TRANSPLANTATION IN MULTIPLE-MYELOMA, British Journal of Haematology, 92(1), 1996, pp. 44-48
A RISK-ADAPTED APPROACH WITH A SHORT-COURSE OF GANCICLOVIR TO PREVENTCYTOMEGALOVIRUS (CMV) PNEUMONIA IN CMV-SEROPOSITIVE RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: VERDONCK LD DEKKER AW ROZENBERGARSKA M VANDENHOEK MR
Citation: Ld. Verdonck et al., A RISK-ADAPTED APPROACH WITH A SHORT-COURSE OF GANCICLOVIR TO PREVENTCYTOMEGALOVIRUS (CMV) PNEUMONIA IN CMV-SEROPOSITIVE RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 1686-1686
LUNG-RESISTANCE PROTEIN EXPRESSION IS A NEGATIVE PREDICTIVE FACTOR FOR RESPONSE TO ALKYLATING CHEMOTHERAPY AND SURVIVAL IN MULTIPLE-MYELOMA
Authors: LOKHORST HM IZQUIERDO MAI RAAIJMAKERS HGP DELEEUW C BELIEN JAM BLOEM AC DEKKER AW SCHEPER RJ SONNEVELD P
Citation: Hm. Lokhorst et al., LUNG-RESISTANCE PROTEIN EXPRESSION IS A NEGATIVE PREDICTIVE FACTOR FOR RESPONSE TO ALKYLATING CHEMOTHERAPY AND SURVIVAL IN MULTIPLE-MYELOMA, Blood, 88(10), 1996, pp. 2549-2549
DISCONTINUATION OF INTRAVENOUS ANTIBIOTIC-THERAPY DURING PERSISTENT NEUTROPENIA IN PATIENTS RECEIVING PROPHYLAXIS WITH ORAL CIPROFLOXACIN
Authors: CORNELISSEN JJ ROZENBERGARSKA M DEKKER AW
Citation: Jj. Cornelissen et al., DISCONTINUATION OF INTRAVENOUS ANTIBIOTIC-THERAPY DURING PERSISTENT NEUTROPENIA IN PATIENTS RECEIVING PROPHYLAXIS WITH ORAL CIPROFLOXACIN, Clinical infectious diseases, 21(5), 1995, pp. 1300-1302
COMPARISON OF CHOP CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR SLOWLY RESPONDING PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA
Authors: VERDONCK LF VANPUTTEN WLJ HAGENBEEK A SCHOUTEN HC SONNEVELD P VANIMHOFF GW KLUINNELEMANS HC RAEMAEKERS JMM VANOERS RHJ HAAK HL SCHOTS R DEKKER AW DEGAST GC LOWENSBERG B
Citation: Lf. Verdonck et al., COMPARISON OF CHOP CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR SLOWLY RESPONDING PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA, The New England journal of medicine, 332(16), 1995, pp. 1045-1051
VAD AND INTERMEDIATE-DOSE MELPHALAN (IDM) AS INDUCTION TO AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - A PHASE-2 STUDY BY THE DUTCH HOVON GROUP
Authors: LOKHORST HM SONNEVELD P CORNELLISSEN JJ DEKKER AW KOOY MV MEUWISSEN OJAT VANOERS MHJ RICHEL DJ WIJERMANS PW
Citation: Hm. Lokhorst et al., VAD AND INTERMEDIATE-DOSE MELPHALAN (IDM) AS INDUCTION TO AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - A PHASE-2 STUDY BY THE DUTCH HOVON GROUP, Blood, 86(10), 1995, pp. 736-736
VARIOUS MODALITIES OF USE OF GM-CSF IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) - A HOVON-SAKK RANDOMIZED STUDY (HOVON-4A)
Authors: LOWENBERG B BOOGAERTS MA VELLENGA E OSSENKOPPELE G DEKKER AW VANDERLELIE J SCHOUTEN HC FOPP M GRATWOHL A FEY M GMUR J VANPUTTEN W
Citation: B. Lowenberg et al., VARIOUS MODALITIES OF USE OF GM-CSF IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) - A HOVON-SAKK RANDOMIZED STUDY (HOVON-4A), Blood, 86(10), 1995, pp. 2035-2035
SHORT AND HIGH-DOSE OF LENOGRASTIM PERMITS PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTION (PBPC) IN PATIENTS WITH AML
Authors: BOOGAERTS MA VANPUTTEN W FERRANT A OSSENKOPPELE G DEKKER AW VELLENGA E HAGENBEEK A WIJEMANS P FEY MJ GRATWOHL A LOWENBERG B
Citation: Ma. Boogaerts et al., SHORT AND HIGH-DOSE OF LENOGRASTIM PERMITS PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTION (PBPC) IN PATIENTS WITH AML, Blood, 86(10), 1995, pp. 3910-3910
MDR-1 EXPRESSION AND RESPONSE TO VINCRISTINE, DOXORUBICIN, AND DEXAMETHASONE CHEMOTHERAPY IN MULTIPLE-MYELOMA REFRACTORY TO ALKYLATING-AGENTS
Authors: CORNELISSEN JJ SONNEVELD P SCHOESTER M RAAIJMAKERS HGP NIEUWENHUIS HK DEKKER AW LOKHORST HM
Citation: Jj. Cornelissen et al., MDR-1 EXPRESSION AND RESPONSE TO VINCRISTINE, DOXORUBICIN, AND DEXAMETHASONE CHEMOTHERAPY IN MULTIPLE-MYELOMA REFRACTORY TO ALKYLATING-AGENTS, Journal of clinical oncology, 12(1), 1994, pp. 115-119
INFECTION PREVENTION IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND THE ROLE OF PROTECTIVE ISOLATION
Authors: DEKKER AW VERDONCK LF ROZENBERGARSKA M
Citation: Aw. Dekker et al., INFECTION PREVENTION IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND THE ROLE OF PROTECTIVE ISOLATION, Bone marrow transplantation, 14(1), 1994, pp. 89-93
TREATMENT OF LOCALIZED NON-HODGKINS-LYMPHOMAS OF THE NEED AND NECK
Authors: RUIJS CDM DEKKER AW VANKEMPENHARTEVELD ML VANBAARLEN J HORDIJK GJ
Citation: Cdm. Ruijs et al., TREATMENT OF LOCALIZED NON-HODGKINS-LYMPHOMAS OF THE NEED AND NECK, Cancer, 74(2), 1994, pp. 703-707
CONVENTIONAL REMISSION INDUCTION FOLLOWED BY INTENSIVE CONSOLIDATION WITHOUT MAINTENANCE THERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS FROM A PHASE-II CLINICAL-TRIAL IN 130 PATIENTS
Authors: DEKKER AW VANTVEER MB HAAK HL VANDERLELIE J OSSENKOPPELE G SCHOUTEN HC SONNEVELD P VANPUTTEN WLJ WILLEMZE R LOWENBERG B
Citation: Aw. Dekker et al., CONVENTIONAL REMISSION INDUCTION FOLLOWED BY INTENSIVE CONSOLIDATION WITHOUT MAINTENANCE THERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS FROM A PHASE-II CLINICAL-TRIAL IN 130 PATIENTS, Blood, 84(10), 1994, pp. 10000144-10000144
ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH A FIXED LOW NUMBER OF T-CELLS IN THE MARROW GRAFT
Authors: VERDONCK LF DEKKER AW DEGAST GC VANKEMPEN ML LOKHORST HM NIEUWENHUIS HK
Citation: Lf. Verdonck et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH A FIXED LOW NUMBER OF T-CELLS IN THE MARROW GRAFT, Blood, 83(10), 1994, pp. 3090-3096
ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS - IMMUNOLOGICAL SUBTYPES AND CLINICAL-FEATURES AT PRESENTATION
Authors: VANTVEER MB VANPUTTEN WLJ VERDONCK LF OSSENKOPPELE GJ LOWENBERG B KLUINNELEMANS JC WIJERMANS PW SCHOUTEN HC SIZOO W DEKKER AW
Citation: Mb. Vantveer et al., ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS - IMMUNOLOGICAL SUBTYPES AND CLINICAL-FEATURES AT PRESENTATION, Annals of hematology, 66(6), 1993, pp. 277-282
Risultati: 1-25 | 26-29